Think smaller: The benefits of a boutique executive search firm

Think smaller: The benefits of a boutique executive search firm

Options are plenty when it comes to executive search firms. On one end of the spectrum are the commandingly large firms, which come with big brand name recognition, high overhead and revenues in excess of $700 million annually. Several of these publicly traded firms have great reputations, but they have historically catered to Fortune 500 companies. If your organization is not a Fortune 500 company, your search can easily get lost in the shuffle or pushed down below the partner level, and costs can quickly exceed your price range. Worse yet, sometimes these firms will try to recruit from your organization after their one or two year hands-off commitment has expired.

Building a unique culture to enhance productivity

Building a unique culture to enhance productivity

A complete end-to-end employee experience can go a long way in raising the business bottom-line but also instill the people with a purpose. Mindi Cox, SVP, People & Great Work, O.C. Tanner, shares her thoughts, in an exclusive interaction with People Matters

First published in People Matters Global: https://www.peoplemattersglobal.com/article/best-practices/building-a-unique-culture-to-enhance-productivity-21468

Your Approach to Hiring Is All Wrong

Your Approach to Hiring Is All Wrong

For most of the post–World War II era, large corporations went about hiring this way: Human resources experts prepared a detailed job analysis to determine what tasks the job required and what attributes a good candidate should have. Next they did a job evaluation to determine how the job fit into the organizational chart and how much it should pay, especially compared with other jobs. Ads were posted, and applicants applied. Then came the task of sorting through the applicants

It’s Time for a C-Level Role Dedicated to Reskilling Workers

It’s Time for a C-Level Role Dedicated to Reskilling Workers

Although corporate leaders have talked about skills gaps for years, the spread of automation and artificial intelligence is prompting some of the biggest companies — including Amazon, JPMorgan Chase, SAP, Walmart, and AT&T, to name just a few — to take action, not with small pilots but with comprehensive plans to retrain large segments of their workforces. These programs signal that the “future of work” is no longer an event on the distant horizon. It’s already here.

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

China’s pharmaceutical industry – shaken by drastic price cuts from Beijing’s recent pilot roll-out of state hospital bulk purchase open bidding – will need to go through painful restructuring and raise big sums to fund innovation, according to executives.

An Overview of Medical Device Regulations in China

An Overview of Medical Device Regulations in China

The National Medical Products Administration (NMPA), previously the China Food and Drug Administration (CFDA), is the institution responsible for pharmaceuticals and medical devices regulations in China. Similarly to the FDA in the United States, the NMPA classifies medical devices into three classes (from I to III) depending on their potential risk. Class I devices are associated with the lowest risk, while Class III devices are associated with the highest risk.

The rise and rise of medtech in Asia

The rise and rise of medtech in Asia

Asia is a region of stark contrasts, with approximately 4.5 billion people—some 60 percent of the world’s population—living in countries with a rich diversity of economic, political, and demographic constituents. With its 48 countries evolving (often rapidly) their political, economic, and healthcare systems, Asia can be a puzzling region to operate in, presenting a steady flow of surprises (and, frequently, challenges).